|
 |
|
|
|
|
Subscribe to Clinical Compass™ |
VOLUME 3, ISSUE 1 - JANUARY 2, 2008 |
|
 |
|
|
|
|
|
|
|
LIVE CME/CE |
 |
|
Multidisciplinary CE Credits Offered!
|
|
View our full CME calendar online!
|
|
|
NEW FORMAT!
neuroscienceCME Journal Club
Featured Article: The impact of obstructive sleep apnea and daytime sleepiness on work limitation
Audioconference + Webcast
Premiere Date:
Monday, January 14, 2008
12:00-12:30 p.m. ET
GUEST
HOST
Thomas Roth, PhD |
FEATURED
AUTHOR
Najib Ayas, MD, MPH |
Read More at Right 
Register Now!
Evaluating and Managing Major Depression: Linking Assessment Measures and Outcomes in Light of the Black Box Warning
Satellite Television Broadcast, Webcast, Telephone Simulcast
Premiere Date:
Wednesday, January 30, 2008
MODERATOR
Madhukar H. Trivedi, MD |
FACULTY
Thomas L. Campbell, MD |
Henry Chung, MD |
Maria A. Oquendo, MD |
Register Now!
Advances in Clinical Care for Patients with Alcohol Dependence
Satellite Television Broadcast, Webcast, Telephone Simulcast
Premiere Date:
Wednesday, February 13, 2008
MODERATOR
Robert R. Conley, MD |
FACULTY
Michael W. Carlton, MD
Christopher W. Shea, MA, CRAT, CAC-AD
Register Now!
Atypicals in Practice: Case Studies on Dosing
Satellite Television Broadcast, Webcast, Telephone Simulcast
Premiere Date:
Wednesday, March 5, 2008
MODERATOR
Charles B. Nemeroff, MD, PhD |
FACULTY
Stephen R. Marder, MD |
Sheldon H. Preskorn, MD |
Register Now!
|
|
SELF-STUDY CME/CE |
|
|
Multidisciplinary CE Credits Offered!
|
|
View our full library of complimentary self-study CE materials!
|
|
|
Practical Management Options for Alcohol Dependence, Part 3 of 3 - Initiating Pharmacotherapy in Patients with Alcohol Dependence
Monograph
Released December 19, 2007
FACULTY
Kyle M. Kampman, MD
Participate Order Online
Expert Discussions on Sleep-Wake Medicine, Part 1 - Recognition, Neurobiology, and Cognitive Impact of Excessive Sleepiness
Podcast
Released December 10, 2007
FACULTY
Charles B. Nemeroff, MD, PhD
Thomas Roth, PhD
Boadie W. Dunlop, MD
David F. Dinges, PhD
Participate
Expert Discussions on Sleep-Wake Medicine, Part 2 - Identifying the Consequences and Improving Outcomes in Patients Exhibiting the Symptom of Excessive Sleepiness
Podcast
Released December 10, 2007
FACULTY
Charles B. Nemeroff, MD, PhD
Leslie P. Lundt, MD
Terri E. Weaver, PhD, FAAN, RN
Mary B. O'Malley, MD, PhD
Participate
From Paper to Patient: Applying Clinical Literature to Practice Improvements, Part 1 - Evidence-Based Medicine: Rationale and Conceptual Framework
Archived Videoconference
Released October 10, 2007
FACULTY
Stephen J. Bartels, MD
Sharon Mozian, MD
Participate Order Online
From Paper to Patient: Applying Clinical Literature to Practice Improvements - Self-Study Practicum
Self-Study Practicum
Released October 15, 2007
FACULTY
Stephen J. Bartels, MD
Sharon Mozian, MD
Participate
From Paper to Patient: Applying Clinical Literature to Practice Improvements, Part 2 - Evidence-Based Medicine: Application of Principles to Practice
Archived Videoconference
Released November 14, 2007
FACULTY
Stephen J. Bartels, MD
Sharon Mozian, MD
Participate Order Online
|
|
|
|
|
|
 |
|
|
FROM THE MAJOR DEPRESSIVE DISORDER CLINICAL KNOWLEDGE CENTER:
The Black Hole of the Black Box for Antidepressants 
THIS ISSUE'S COMPASS QUESTIONS™
INTRODUCING neuroscienceCME JOURNAL CLUB!
2008 neuroscienceCME TV PREMIERE!
Evaluating and Managing Major Depression: Linking Assessment Measures and Outcomes in Light of the Black Box Warning
|
 |
|
|
FROM THE MAJOR DEPRESSIVE DISORDER CLINICAL KNOWLEDGE CENTER
The Black Hole of the Black Box for Antidepressants
Depression is a common and treatable illness. In 2006, 15.8 million adults (7.2% of persons aged 18 or older) reported having at least one Major Depressive Episode (MDE) in the past year. The mainstay of pharmacotherapy for major depression are antidepressant (AD) medications, including SSRIs, SNRIs, tricyclic antidepressants, and novel agents such as bupropion.
Like all medications, AD have side effects that may limit their use under some circumstances or in some patients. The most common side effects are headache, nausea, dry mouth, and constipation, which although distressing, are not life-threatening and are often transient or tolerable. On the other hand, there has been a long-standing debate over whether these medications also may increase the risk of suicide, and this requires more careful analysis of risks and benefits...
Read entire article
Back to top 
|
|
|
|
INTRODUCING neuroscienceCME JOURNAL CLUB!
neuroscienceCME Journal Club was designed for clinicians who have made a commitment to staying current. Each month, neuroscienceCME Journal Club will evaluate emerging literature and present it in a concise 30-minute audioconference + webcast format that showcases the authors as they are interviewed by guest hosts who are also experts in the field. The result is a tight capsule full of valuable takeaway points that can be immediately applied to clinical practice.
Premiering on January 14, 2008, neuroscienceCME Journal Club will begin with a special series on Sleep-Wake Medicine. International sleep specialist Thomas Roth, PhD, will host four interview segments on this topic. In each session, a guest author will join Dr. Roth to provide a brief synopsis of a recently published scientific work. Dr. Roth and his guest will engage in a lively discussion about the merits of the article, its implications for the field of sleep-wake medicine, and key practice points arising from the data published in the article. A live Q&A session will follow where participants may submit questions and comments to Dr. Roth and his guest.
New installments will debut on the 2nd Monday of every month from 12:00-12:30 p.m. ET. Dates for the 2008 Sleep-Wake Medicine series are January 14, February 11, March 10, and April 14.
Please note that this activity is not certified for CME/CE credit.
Visit neuroscienceCME.com/journalclub for topics, dates, times, and registration information for this free resource. Because this service is designed to deliver late-breaking information, specific topics and guest authors will be announced at neuroscienceCME.com as they become available.
Back to top
|
|
|
2008 neuroscienceCME TV PREMIERE!
Evaluating and Managing Major Depression: Linking Assessment Measures and Outcomes in Light of the Black Box Warning
Premiere Date: Wednesday, January 30, 2008
Live Broadcast: 12:00-1:00 p.m. ET
Taped Re-Air: 3:00-4:00 p.m. ET
ACTIVITY GOAL
To recognize somatic symptoms that may underlie, but mask, a diagnosis of Major Depressive Disorder; to analyze the contribution of primary care physician education on reducing suicide rates by increasing levels of depression treatment, and to identify pharmaceutical and psychological measures to achieve depression remission.
LEARNING OBJECTIVES
At the end of this CE activity, participants should be able to:
- Identify presentation of somatic symptoms that could underlie a diagnosis of Major Depressive Disorder (MDD).
- Formulate appropriate treatment plans and goals for those diagnosed with MDD.
- Evaluate the usefulness of PCP education on the diagnosis and management of MDD.
CREDIT INFORMATION
This activity offers CE credit for:
- Physicians (ACCME/AMA PRA Category 1)
- Nurses (CNE)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Back to top
|
|
|
|
|
|
|
|
|
|
Problems receiving e-mail from us? Add webmaster@cmeoutfitters.com to your address book.
CME Outfitters, LLC, reserves the right to cancel any activity or make necessary changes in dates, times, speakers, content, and other details without notice. CME Outfitters, LLC, and the commercial supporters of these activities are not responsible for any speaker's or registrant's statements, materials, acts, or omissions.
|
|
|
|
|
©2008 CME Outfitters, LLC
|
|
|
|
